Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'mcl1 in 1'

Search results for: 'mcl1 in 1'

Items 21-30 of 108

Page
per page
  1. Imatinib Mesylate (STI571)
    A1805 Imatinib Mesylate (STI571)
    Target: PDGFR|c-Kit|Bcr-Abl
    Summary: Abl/c-kit/PDGFR inhibitor
      ≥29.5 mg/mL
  2. CP-724714
    A2412 CP-724714
    Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1R
    Summary: HER2 inhibitor,potent and selective
      ≥23.5 mg/mL
  3. SB525334
    A5602 SB525334
    Summary: (TGF-beta1) receptor inhibitor
      ≥34.3 mg/mL
  4. R428
    A8329 R428
     10 Citation
    Summary: Selective Axl inhibitor
      ≥25 mg/mL
  5. Varlitinib (ARRY334543)
    A8365 Varlitinib (ARRY334543)
    Summary: ErbB inhibitor
      ≥23.35 mg/mL
  6. MK-2461
    A8476 MK-2461
    Target: FLT3|PDGFR|MET|Ron
    Summary: C-Met (WT/mutants) inhibitor
      ≥24.8 mg/mL
  7. R406
    A8546 R406
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and ATP-competitive
      ≥31.45 mg/mL
  8. PF-431396
    A8692 PF-431396
    Summary: Pyk2 and FAK inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL
  9. Ki20227
    A3527 Ki20227
    Target: c-Fms tyrosine kinase
    Summary: C-Fms tyrosine kinase inhibitor
      ≥48.1 mg/mL
  10. KX2-391 dihydrochloride
    A3535 KX2-391 dihydrochloride
    Target: Src
    Summary: Src kinase inhibitor
      ≥25.2 mg/mL

Items 21-30 of 108

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 5item
  2. Axl 3item
  3. ALK 7item
  4. BMX Kinase 1 item
  5. Broad Spectrum Protein Kinase Inhibitor 3item
  6. c-FMS 2item
  7. c-Kit 2item
  8. c-MET 4item
  9. c-RET 3item
  10. CSF-1R 1 item
  11. DDR1/DDR2 Receptor 1 item
  12. EGFR 12item
  13. FAK 3item
  14. FGFR 8item
  15. FLT3 7item
  16. HER2 4item
  17. IGF1R 5item
  18. Insulin Receptor 2item
  19. IRAK 3item
  20. ITK 1 item
  21. Lck 1 item
  22. LRRK2 4item
  23. PDGFR 9item
  24. Pyk2 1 item
  25. ROR 2item
  26. Spleen Tyrosine Kinase (Syk) 3item
  27. Src 8item
  28. Tie-2 2item
  29. Trk 1 item
  30. VEGFR 26item
Specificity
  1. Selective 44item
Reversibility
  1. Reversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 3item
  3. Aurora Kinases 1 item
  4. CSF-1R 1 item
  5. FLT3 6item
  6. VEGFR 22item
  7. PDGFR 12item
  8. c-Kit 6item
  9. RET 2item
  10. IRAK 3item
  11. Bcr-Abl 6item
  12. FGFR 4item
  13. Insulin-like growth factor receptors(IGFRs) 1 item
  14. MET 1 item
  15. Src 7item
  16. Trk Receptors 2item
  17. EGFR 2item
  18. BMP and Other Activin Receptors 1 item
  19. JAK 1 item
  20. Syk 3item
  21. c-MET 3item
  22. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  23. LRRK2 2item
  24. Insulin and Insulin-like Receptors 1 item
  25. ALK 1 item
  26. Tie-2 2item
  27. Ron 1 item
  28. c-Fyn 1 item
  29. Insulin Receptors 1 item
  30. IRG-1R 1 item
  31. ZAP-70 1 item
  32. Fyn kinase 1 item
  33. c-Fms tyrosine kinase 1 item
  34. Mer tyrosine kinase 1 item
  35. ITK 1 item
  36. DCLK2 1 item
Reported Experiments
  1. Animal Experiments 50item
  2. Cell Experiments 35item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 2item
  6. Breast Cancer 9item
  7. Cancer 33item
  8. Cervical Cancer 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 1 item
  11. Colon Carcinoma 3item
  12. Colorectal Cancer 8item
  13. Glioblastoma 3item
  14. Glioma 1 item
  15. Leukemia 2item
  16. Liver Cancer 1 item
  17. Lung Cancer 4item
  18. Lung Carcinoma 2item
  19. Lymphoma 2item
  20. Melanoma 1 item
  21. Multiple Myeloma 2item
  22. Myeloma 1 item
  23. Non-small Cell Lung Cancer 3item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 2item
  26. Prostate Cancer 3item
  27. Pulmonary Arterial Hypertension 1 item
  28. Renal Cancer 2item
  29. Renal Cell Carcinoma 2item
  30. Thyroid Cancer 3item